Trial Profile
USE OF TRABECTEDIN IN PATIENTS WITH RELAPSED/PROGRESSION OF EPITHELIAL OVARIAN CARCINOMA
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2012
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Trabectedin (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 22 Mar 2012 New trial record